21 May 2009
Diagnostic and treatment strategy of invasive aspergillosis based on galactomannan screenning – prospective analysis of 268 patients after hematopoietic stem cell transplantation
L Gil, M Kozlowska-Skrzypczak, A Czyz, A Lojko-Dankowska, A Nowicki, M KomarnickiAnn Transplant 2009; 14(1): 21-22 :: ID: 880276
Abstract
Background: The outcome of invasive aspergillosis (IA) after hematopoietic
stem cell transplantation (HSCT) depends on early diagnosis and treatment initiation. The aim of the study was to assess the efficacy of Aspergillus' antigen galactomannan-based diagnostic and treatment strategy in HSCT recipients.
Material/Methods: A total of 268 patients (median age 42; range 18-68) undergoing autologous (181) or allogeneic (87) HSCT were prospectively analyzed. All patients were monitored with twice-weekly serum galactomannan (GM) test. High resolution thoracic tomography (HRCT) and bronchoscopy with lavage were performed in case of positive GM test, persistent fever or pulmonary infiltrates. The diagnosis of IA was made according to EORTC/MSG criteria.
Results: Among patients after allogeneic HSCT documented IA was diagnosed in 17 (19.5%) patients (4 proven, 13 probable) and possible in 13 (15%). Median time to diagnosis of documented IA was 69 (range; 10-515) days. After autologous HSCT documented IA was established in 12 (6.5%) patients (5 proven, 7 probable) and possible in 48 (25.5%). Median time to diagnosis of documented IA in this group was 15 (range; 8-38) days. All patients with documented IA were treated with voriconazole. In 12 weeks follow up 11 (38%) patients died because of IA. In case of possible IA, amphotericin B or caspofungin were used. In this group 4 patients died due to confirmed bacterial infection. In summary: IA represents serious infectious complication both after allogeneic and autologous HSCT. Strategy based on GM screening, HRCT and bronchoscopy allows early diagnosis of IA and early pre-emptive or targeted therapy.
Keywords: fungal infections, Stem Cell Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860